AstraZeneca (AZN) Earnings Analysis
AstraZeneca (AZN) next reports earnings on 2026-07-27, consensus EPS 2.1 USD. Last quarter (2026-04-29) it beat with EPS 2.58 USD vs 2.57 USD est (+0.4%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E 25.04.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AZN next report earnings?
| Next earnings date | 2026-07-27 |
|---|---|
| Consensus EPS estimate | 2.1 USD |
| Revenue estimate | 15.44B |
AZN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-29 | 2.58 USD | 2.57 USD | +0.4% | Beat |
| 2025-02-06 | 2.1 USD | 2.07 USD | +1.4% | Beat |
| 2024-07-25 | 1.98 USD | 1.97 USD | +0.5% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
AZN valuation and analyst view
| Trailing P/E | 25.04 |
|---|---|
| Trailing EPS | 13.5 USD |
| Price / book | 5.52 |
| Dividend yield | 1.87% |
| Market cap | 131.35B |
| Analyst consensus | Buy (20 buy / 15 hold / 6 sell) |
| Avg price target | 211 USD |
Related research pages
Frequently asked questions
When is AstraZeneca (AZN)'s next earnings date?
AstraZeneca is next scheduled to report on 2026-07-27, with a consensus EPS estimate of 2.1 USD and revenue estimate of 15.44B.
Did AZN beat earnings last quarter?
In its 2026-04-29 report, AZN posted EPS of 2.58 USD versus a 2.57 USD estimate — a beat of 0.4%.
What is AZN's earnings track record?
Over the last 3 reported quarters with consensus data, AZN beat estimates 3 times (100%).
What is AZN's current P/E ratio and EPS?
AZN trades at a trailing P/E of 25.04 on trailing EPS of 13.5 USD.
What do analysts rate AZN?
Analyst consensus is "Buy" across 41 ratings (1 strong buy, 19 buy, 15 hold, 6 sell, 0 strong sell). Average 12-month price target: 211 USD.